상품 옵션 정보 | |||||||
---|---|---|---|---|---|---|---|
카탈로그 번호 | 설명 | 상태 | 단위 | 판매가 | 할인가 | 가격(VAT포함) | 수량 / 장바구니 / 찜 |
SAB4200815-25UL | Merck SAB4200815-25UL Anti-VEGF165 antibody, Mouse monoclonal, 25uL pk | 재고문의 | pk | 284,970원 | - | 313,467원 |
Anti-VEGF165 antibody, Mouse monoclonal
clone VG-20, purified from hybridoma cell culture
VEGF-A, Vascular permeability factor, Vascular endothelial growth factor A, VPF
생물학적 소스
mouse
항체 형태
purified from hybridoma cell culture
antibody product type
primary antibodies
클론
VG-20, monoclonal
species reactivity
human
포장
antibody small pack of 25 μL
농도
~1 mg/mL
technique(s)
immunoblotting: 1-2 μg/mL using recombinant human VEGFA protein expressed in HEK-293
동형
IgG1
UniProt 수납 번호
배송 상태
dry ice
저장 온도
−20°C
Gene Information
human ... VEGF165(7422)
VEGFA - Vascular Endothelial Growth Factor A, also known as or Vascular permeability factor (VPF), is a major signaling growth factor member of the VEGF family, sub-group of the Platelet-Derived Growth Factor (PDFG) proteins, which is characterized by its conserved cystine-knot structure.1 VEGF expression is up regulated in hypoxia and in many types of cancers. Furthermore, VEGF receptors (VEGFR1 and VEGFR2) are also overexpressed in several tumors and studies have shown that high levels of VEGF correlates with poor prognosis.1-8 Inhibition of VEGF mediated angiogenesis signaling pathways have potential in angiogenesis-related disease therapy, this can be achieved by blocking either the circulating VEGF using Anti-VEGF antibodies such as Bevacizumab and Aflibercept5 or by VEGFR-2 inhibition using small molecules such as Gamabufotalin (CS-6) and Arenobufagin.6-8
배송/결제/교환/반품 안내
배송 정보
기본 배송비 |
| 교환/반품 배송비 |
|
---|---|---|---|
착불 배송비 |
| ||
교환/반품 배송비 |
|
결제 및 환불 안내
결제 방법 |
|
---|---|
취소 |
|
반품 |
|
환급 |
|
교환 및 반품 접수
교환 및 반품 접수 기한 |
|
---|---|
교환 및 반품 접수가 가능한 경우 |
|
교환 및 반품 접수가 불가능한 경우 |
|
교환 및 반품 신청
교환 절차 |
|
---|---|
반품 절차 |
|